Unity Biotechnology CEO Anirvan Ghosh receives $7.4M in 2020
Unity Biotechnology reports 2020 executive compensation
By ExecPay News
Published: April 30, 2021
Unity Biotechnology reported fiscal year 2020 executive compensation information on April 30, 2021.
In 2020, four executives at Unity Biotechnology received on average a compensation package of $3.2M, a 57% increase compared to previous year.
Anirvan Ghosh, Chief Executive Officer, received $7.4M in total. 56% of Ghosh's compensation, or $4.2M, was in option awards. Ghosh also received $75K in bonus, $213K in non-equity incentive plan, $417K in salary, $2.5M in stock awards, as well as $54K in other compensation.
Lynne Sullivan, Chief Financial Officer, received a compensation package of $2.9M. 67% of the compensation package, or $1.9M, was in option awards.
Jamie Dananberg, Chief Medical Officer, earned $1.9M in 2020, a 20% increase compared to previous year.
Keith R. Leonard Jr, Chief Executive Officer, received $576K in 2020, which decreases by 82% compared to 2019.